Analysis

Pa. Stuck In Litigation Limbo As Purdue Inks 1st Opioid Deal

Law360 (April 5, 2019, 8:30 PM EDT) -- As litigation over damages from the opioid epidemic moves ahead across the nation, including Purdue Pharma’s recent $270 million deal to end claims in Oklahoma, attorneys in Pennsylvania are expressing frustration about the slow pace of progress in the year and a half since the first cases were filed there.

While trials in Oklahoma and in an Ohio-based federal multidistrict litigation have been scheduled for May and October, respectively, the latest progress in coordinated cases in Pennsylvania was a judge’s order Wednesday setting a date for argument at the end of the month over who should serve as co-lead counsel....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!